Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001471714-10-000003
Filing Date
2010-06-11
Accepted
2010-06-11 11:08:41
Documents
2
Period of Report
2010-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2495
2 EDGAR SUPPORTING DOCUMENT poa-dreismann_2.txt EX-24 3211
  Complete submission text file 0001471714-10-000003.txt   7402
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4253 GOLDEN OAK CT DANVILLE CA 94506
Business Address
DREISMANN HEINRICH (Reporting) CIK: 0001471714 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 10891867